GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · BSE Equity Only

BSE Exchange Filings, Explained Simply

AI-powered plain-English analysis of every important BSE announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Today
—
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Strictly sourced from BSE exchange announcements (equity segment only). We show only material, important filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India exchange announcements. More categories will be added over time.
Bal Pharma Ltd
Bal Pharma Ltd: Rs. 1.20 Dividend Paid FY 2025-26
DIVIDEND ▲ Positive Development LOW RISK
📅 Filed on BSE: 13 Oct 2026, 11:52 AM IST  ·  BSE ID: 3325a2b2-16d9-4208-854d-71333ed4855a
View Original BSE Filing (PDF)
💡
In Simple Terms
The company has paid out its final dividend for the past financial year, but some payments are on hold for shareholders with missing information.
🤖 AI Summary
  • Bal Pharma Ltd disbursed ₹1.20 per equity share as final dividend for FY 2025-26.
  • Dividend payment completed on October 9, 2026, to eligible shareholders.
  • AGM on September 24, 2026, approved the final dividend for FY 2025-26.
  • Dividend withheld for shareholders with incomplete KYC or invalid bank details.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Final dividend per equity share
₹1.20
Face value per equity share
₹10
Financial Year
2025–26
AGM Date
September 24, 2026
Record Date
September 17, 2026
Dividend Disbursement Date
October 9, 2026
🏢 How This Affects the Company
💰
Financial Impact
The dividend disbursement represents a cash outflow from the company's reserves to shareholders.
⚠️
Risk Impact
The withholding of dividends for certain shareholders highlights a need for improved data accuracy in their records.
👥 What This Means For Shareholders
✅
Action Required
Shareholders should verify dividend credit and check TDS details on their Income Tax e-filing portal.
👤
Who Is Affected
All eligible shareholders of Bal Pharma Ltd registered as on September 17, 2026, have received the dividend, subject to KYC and bank account validity.
🔍
Management Signal
Management has confirmed adherence to corporate governance by completing dividend disbursement post-AGM approval.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Next AGM announcement for FY 2026-27 dividend.
Shareholder communication on KYC/bank detail updates.
Annual report for FY 2026-27 for detailed financial review.
LOW RISK Routine dividend payment announcement with standard disclosures for incomplete KYC.
💡 Investor Takeaway
Bal Pharma Ltd completed the disbursement of a ₹1.20 per equity share final dividend for FY 2025-26 on October 9, 2026. Dividend payment was remitted via electronic modes to eligible shareholders with validated bank details.
⚖️ Strengths & Concerns

✅ Positives

  • Final dividend of ₹1.20 per equity share paid for FY 2025-26.
  • Dividend disbursed on October 9, 2026, within prescribed timelines.
❓ Frequently Asked Questions
What is the final dividend per share declared by Bal Pharma Ltd for FY 2025-26?
Bal Pharma Ltd declared a final dividend of ₹1.20 per equity share for the financial year 2025-26.
When was the final dividend for FY 2025-26 disbursed by Bal Pharma Ltd?
The final dividend for FY 2025-26 was disbursed on October 9, 2026.
Who approved the final dividend for FY 2025-26 at Bal Pharma Ltd?
The members of Bal Pharma Ltd approved the final dividend at their 39th Annual General Meeting held on September 24, 2026.
Why might a shareholder not have received their dividend payment?
Dividend payments are withheld for shareholders with incomplete KYC, invalid bank account details, or closed bank accounts.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.